AI-Enabled Drug Discovery and Clinical Trials Market Size, Share, By Offering (Software Solutions and Services), Therapeutic Area (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Diseases, Infectious Diseases, and Others), Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, and Biomarker Research), End-User (Biopharmaceutical Industry, Contract Research Organizations (CROs), Academic and Research Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

AI-Enabled Drug Discovery and Clinical Trials Market Size

AI-Enabled Drug Discovery and Clinical Trials Market Size was valued at USD 1.7 billion in 2025 and is expected to reach USD 19.8 billion by 2035 growing at a CAGR of 30.9%.

AI-enabled drug discovery and clinical trials use AI technology to identify and test novel medications, predicting efficacy, toxicity, and patient response. With increasing healthcare adoption, reimbursement policies, chronic diseases, and cancer prevalence, this technology can reduce costs, improve efficiency, and accelerate drug development, fueling AI-enabled drug discovery and clinical trials market growth.